HealthcareServices

Global Cell Lysis And Fractionation Industry Trends and Market Forecast 2026–2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cell lysis and fractionation market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Cell Lysis And Fractionation Market between 2026 and 2030?

The cell lysis and fractionation market has demonstrated robust expansion over recent years. Its valuation is anticipated to increase from $3.69 billion in 2025 to $3.95 billion in 2026, representing a compound annual growth rate (CAGR) of 7.0%. This historical growth can be attributed to an uptick in molecular biology research, a rise in proteomics investigations, the increasing application of nucleic acid purification techniques, the enlargement of life science laboratories, and a greater need for standardized sample preparation.

The cell lysis and fractionation market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $5.16 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.9%. This projected growth during the forecast period is driven by factors such as increasing investments in proteomics and genomics research, the rising adoption of automated sample preparation, a heightened focus on high-throughput analysis, the expansion of biopharmaceutical research pipelines, and the growing use of integrated laboratory systems. Prominent trends observed in this period include the increasing adoption of automated cell lysis systems, a rising demand for high-efficiency protein extraction, the growing utilization of chemical and mechanical lysis methods, the expansion of fractionation-based sample preparation, and an enhanced focus on sample integrity.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

Which Drivers Are Expected To Impact The Cell Lysis And Fractionation Market During The Forecast Period?

A heightened emphasis on personalized medicine is anticipated to fuel the expansion of the cell lysis and fractionation markets in the future. This innovative medical approach utilizes a person’s unique genetic information to diagnose and treat illnesses, customizing medical choices and therapies based on each patient’s specific genetic characteristics. Cell lysis and fractionation are vital to precision medicine, enabling the isolation and examination of specific subcellular components, such as proteins, organelles, and nucleic acids, from patient specimens. This capability allows researchers and healthcare providers to delve into the molecular mechanisms of diseases and develop individualized treatments tailored to each patient’s distinct molecular profile. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the Food and Drug Administration (FDA) approved 7 new personalized treatments for cancer in 2023, as part of a total of 26 personalized treatments, which was a notable rise from the 12 approved in 2022. Consequently, the increasing focus on personalized medicine is a key factor propelling the growth of the cell lysis and fractionation markets.

Which Segments Are Driving Activity In The Cell Lysis And Fractionation Market?

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

How Are New Market Trends Shaping The Landscape Of The Cell Lysis And Fractionation Market?

Leading companies in the cell lysis and fractionation market are concentrating on launching advanced solutions, such as CGT (cell and gene therapy) viral vector lysis kits, to gain an advantage in the market. These specific lysis kits provide a simplified AAV (Adeno-associated virus) lysis method designed to improve Standard Operating Procedures (SOPs), quality control, and safety, while also standardizing bioprocessing operations. As an illustration, in July 2023, QIAGEN, a Germany-based supplier of sample and assay technologies, introduced its new CGT Viral Vector Lysis Kit, enabling the quantification of virus titers for multiple serotypes through an exact and consistent procedure starting from cell lysates. This new CGT viral vector lysis kit complements QIAGEN’s quickly expanding digital PCR portfolio for the biopharma sector, which already features three QIAcuity Residual DNA Quantification Kits for checking host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays intended for adeno-associated virus (AAV) titer quantification.

Which Key Market Players Are Investing In Expansion And Innovation Within The Cell Lysis And Fractionation Market?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Which Regions Are Poised For Strategic Growth In The Cell Lysis And Fractionation Market?

North America was the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Lysis And Fractionation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14064&type=smp

Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2026, By The Business Research Company

Cell Expansion Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Plasma Fractionation Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Cell Separation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-separation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795